Figure 1.
(a) Arylpiperazine lead, showing HB interaction between its 4-acetyl group and the putative target. (b) Design of piperazine analogues, via replacement of acetyl with oxazole or benzoxazole. (c) Compound 41, showing its HB interactions with the putative target.